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INTRODUCTION 
 
Breast cancer is a major concern worldwide and is responsible for one of the 
highest causes of death all over world including india. The chance that breast cancer 
will be  responsible for a woman’s death is about 1 in 35 cases. Researches are trying 
to discover new biomarkers that might be better for diagnosis, prognosis,treatment 
monitoring and to develop new drugs that might work better against breast cancer.     
. 
Prostate specific antigen is a 33 k Da serine protease expressed at high level in 
prostate epithelium and elevated PSA in serum is well established marker of prostate 
cancer. Numerous studies have demonstrated the production of PSA in female tissue 
such as breast, endometrium and ovary are similar to prostate since their growth and 
differentiation are controlled by steroid hormones  and low levels of PSA are present 
in female serum.   
Thus serum prostate specific antigen level in patients with carcinoma breast is 
comparable  with normal serum PSA level in females which is about 0.1-0.9 ng/ml . 
This prospective study is designed to evaluate the diagnostic value of serum 
prostate specific antigen level in carcinoma breast. 
 
 
AIMS & OBJECTIVES:   
 
1. To know the usefulness of prostate specific antigen as a biomarker marker  in  
carcinoma breast 
2. To compare the level of serum prostate specific antigen in patients with 
carcinoma breast with normal standartised level   and to  compare the 
preoperative and postoperative serum PSA level in patients with carcinoma 
breast.  
 
 
MATERIALS AND METHODS 
 
PLACE OF STUDY: 
 
 Department of General Surgery, Govt.  Stanley Medical College and Hospital 
 
 
 
DURATION: 
 
  JAN 2014 TO SEP 2014 
 
 
 
STUDY DESIGN: 
 
 Comparitive  study 
 
SAMPLE SIZE : 50 
 
 
 
INCLUSION CRITERIA: 
 
1. Patients presenting with lump in the breast which proven to be carcinoma 
through tissue diagnosis. 
 
 
EXCLUSION CRITERIA: 
 
1. Patients with lump in the breast  which proven to be benign  through tissue 
diagnosis and patients with associated ovarian and uterine pathology.  
 
 
 
 
 
METHODOLOGY: 
 
 Patients presenting with clinical features of lump over breast, who getting 
admission as in-patient in ward  of our hospital from January 2014 to 
November 2014 will be enrolled in our study.  
 Serum prostate specific antigen, sonographic study of breast, tissue diagnosis of 
lump will be done simultaneously.  
 Serum prostate specific antigen level will be compared with normal standard 
level in patients proven to be carcinoma breast through tissue diagnosis. 
 Observations are tabulated according to the pre-designed proforma.   
 The results are analyzed using Microsoft Excel for tabular transformation and 
graphical representation. For comparing the parameters, Chi Square test or 
Fischer’s exact test are used. SPSS  software will be used for statistical 
analysis. 
                                         CONCLUSION 
 
This study conducted in an attempt to know, if serum PSA  
 
measurement in  Female patients with carcinoma breast   have  
 
any diagnostic, prognostic or  monitoring value. Serum PSA  
 
level of breast cancer patients were  compared with  
 
standardized normal level and pre surgical and post  
 
surgical  levels are also been compared. After statistical  
 
ananlysis, the  conclusion made that, there is no significant  
 
correlation between serum  PSA level and carcinoma breast and  
 
no significant difference between  Pre surgical and post surgical  
 
serum PSA level in patients with carcinoma  breast. In prostate,  
 
PSA enters the circulation by physical diffusion.  
 
     Factors that affects the transport of  PSA from tissue to blood  
 
     may also be  considered  at this point and also the tumor  behavior 
 
    of  the westerner and Asians  may  be considered for its significant  
 
    change of PSA. 
 
                                KEY WORDS 
 
 
 
 
 CARCINOMA BREAST 
 PROSTATE SPECIFIC ANTIGEN[PSA] 
 SERUM MARKER 
 BREAST TISSUE 
 PRESURGICAL LEVEL 
 POST SURGICAL LEVEL 
 
 
 
 
 
 
 
 
 
REFERENCES 
1. Armbruster da[1993].prostate specific antigen;biochem analytical methods and 
clinical application 
